The Tamiflu Trials: Profit and Public Health--How Do We Choose Which Drugs to Use?


Before Remdesivir and Hydroxycloroquin there was Tamiflu.

To prepare for Swine Flu and Bird Flu, governments spent billions stockpiling this drug called Tamiflu. You’d think governments used the best evidence-based advice, but the story of Tamiflu raises questions about how money shaped the process.

On this episode of Cited, Darts and Letters predecessor, we open up the black box of pharmaceutical and public health expertise. We tell the story of a drug, from its days as middling flu treatment through its meteoric rise to international blockbuster. How do experts decide what makes a good drug, and how do pharmaceutical companies make billions from pandemic panic?

—————————-SUPPORT THE SHOW—————————-

You can support the show for free by following or subscribing on Spotify, Apple Podcasts, or whichever app you use. This is the best way to help us out and it costs nothing so we’d really appreciate you clicking that button.

If you want to do a little more we would love it if you chip in. You can find us on Patrons get content early, and occasionally there’s bonus material on there too.

——————-ABOUT THE SHOW——————

For a full list of credits, contact information, and more, visit our about page.

Your Host

Gordon Katic

Gordon Katic is an award-winning radio producer and journalist with a background in health, science, and climate reporting. He is director of Cited Media Productions, which produced Cited Podcast and CRACKDOWN. Now, Gordon hosts Darts and Letters. When he’s not making podcasts, he’s working on a PhD at the University of Toronto focussed on theorizing a critical theory of science communication. Previously, he earned a Masters in Journalism from the University of British Columbia.

View Profile